Figure 8.

Efficacy of STCV/4T1, STCV/NC and STCV/sPD‐1 on 4T1 tumor treatment. Mice were injected with STCV/4T1, STCV/NC, or STCV/sPD‐1 on days 3 and 5 for twice after 4T1 tumor cells were challenged as indicated. A‐D, Individual tumor growth (gray lines) and mean tumor growth (black line) in groups of PBS, STCV/4T1, STCV/NC, and STCV/sPD‐1 treatment are shown. E, Tumor‐free curves of mice in each group. F, Survival curves of mice in each group. NC, negative control; sPD‐1, soluble programmed death receptor‐1; STCV, senescent tumor cell vaccine